HOXD9 and metabolic dysfunction-associated steatotic liver disease: Survival analysis of these 18 MDEGs was performed, and the results indicated that the expression of DGKK (p-value = 0.038) and HOXD9 (p-value <0.001) was significantly correlated with the overall survival time of NAFLD patients (Fig. 5).